|
|
|
|
Characteristics and Antiviral Treatment Patterns Among US Adults With Laboratory-Confirmed Hepatitis Delta Virus vs Hepatitis B Virus Monoinfection
|
|
|
AASLD Nov 15-19, 2024 San Diego, CA
Robert J Wong1,2, Robert G Gish3, Ira M Jacobson4, Joseph K Lim5, Marvin Rock6, Gary Leung7, Chong Kim6
1Stanford University School of Medicine, Stanford, CA, USA; 2VA Palo Alto Healthcare System, Palo Alto, CA, USA; 3Hepatitis B Foundation, Doylestown, PA, USA; 4New York University Grossman School of Medicine, New York, NY, USA; 5Yale School of Medicine, New Haven, CT, USA; 6HEOR-Global Value & Access, Gilead Sciences, Inc., Foster City, CA, USA; 7RWE-Epidemiology, Gilead Sciences, Inc., Foster City, CA, USA
|
|
|
|
|
|
|